Results 291 to 300 of about 157,236 (308)
Some of the next articles are maybe not open access.

Insights from von Willebrand disease animal models

Cellular and Molecular Life Sciences, 1999
Cecile Denis   +2 more
exaly  

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

Best Practice and Research in Clinical Haematology, 2001
Jeroen Eikenboom, J C Eikenboom
exaly  

Type 2M von Willebrand disease – more often misidentified than correctly identified

Haemophilia, 2016
E. Favaloro   +8 more
semanticscholar   +1 more source

A molecular approach to the classification of von Willebrand disease

Best Practice and Research in Clinical Haematology, 2001
Reinhard Schneppenheim   +2 more
exaly  

von Willebrand factor and von Willebrand disease.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2016
T. Matsui, J. Hamako
semanticscholar   +1 more source

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

Best Practice and Research in Clinical Haematology, 2001
Anne-Sophie Ribba   +2 more
exaly  

Treatment of von Willebrand Disease

Seminars in Thrombosis and Hemostasis, 2016
J. Curnow, Leonardo Pasalic, E. Favaloro
semanticscholar   +1 more source

Von Willebrand factor and von Willebrand disease

Von Willebrand disease (vWD) is an autosomally inherited bleeding disorder caused by a deficiency or abnormality of von Willebrand factor (vWF). vWF is a large multimeric glycoprotein that mediates platelet adhesion at the site of vessel injury. Also, it protects factor VIII from proteolytic degradation in the circulation. vWD has a prevalence of about
openaire   +1 more source

Home - About - Disclaimer - Privacy